Blonde, L., Bailey, T. S., Chao, J., Dex, T. A., Frias, J. P., Meneghini, L. F., . . . Aroda, V. R. (2019). Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial. Adv Ther.
Citação norma ChicagoBlonde, Lawrence, Timothy S. Bailey, Jason Chao, Terry A. Dex, Juan Pablo Frias, Luigi F. Meneghini, Michelle Roberts, and Vanita R. Aroda. "Clinical Characteristics and Glycemic Outcomes of Patients With Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial." Adv Ther 2019.
MLA引文Blonde, Lawrence, et al. "Clinical Characteristics and Glycemic Outcomes of Patients With Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial." Adv Ther 2019.